ViOptix spies $895K to measure tissue oxygen
ViOptix, maker of a device that measures tissue oxygen levels for various medical applications, has brought in $895,000 in equity and debt, according to a filing with the SEC. Last December, during an especially tough time for biotech companies, it successfully raised $4.4 million, closing its fourth round of financing at $16.6 million.
The Fremont, Calif. company is funded by Canadian Medical Discoveries Fund, Channel Medical Partners and Morningside Technology Ventures, BioAsia Management and Lincoln Funds… Continue Reading
ViOptix snags $7.4M to measure tissue oxygen
Biotech firm ViOptix just tacked $4.4 million onto an already $12.2 million fourth round of funding and landed $3 million in debt financing to break even, reports VentureWire. The Fremont, Calif. company says this will be its last round of venture capital.
Around since 1999, ViOptix has pioneered a device that allows doctors to detect how much oxygen exists in human tissues through a non-invasive procedure. No plans for the new money, beyond self-sufficiency, have been… Continue Reading
Plastic Logic sees flexible, low-power displays coming with $50M funding
Thin, flexible display tech is one of those advances that has been just over the horizon since the Internet bubble started inflating. Remember the promises of e-paper — a crossbreed with the best qualities of both paper and computer screens, used as portable reading material? So far the best we’ve gotten is the Amazon Kindle, but Plastic Logic is hoping to change that, with a plan for commercialization next year.
Plastic Logic, spun off from Cambridge… Continue Reading
Life sciences briefing: Thursday, Jan. 10, 2008
TODAY’S HEADLINES:
ViOptix pulls in $12M for tissue-oxygen sensors (release)
Tethys Bioscience raises funding, preps diabetes-prediction test (release)
Synergy Life Sciences closes $143M medical-device fund (release)
Venture-backed Go Fig. files for bankruptcy protection (VentureWire, sub req’d)
Whole-genome sequencer Knome strikes deal with Beijing Genomics Institute (release)
Omeros, inflammation and CNS drug developer, files for $115M IPO (Edgar)
Clinipace, clinical-trial software maker, seeks $2.6M (Triangle Business Journal)
Seno Medical receives $1M from Texas state fund(release)
Cardiovascular Systems pulls in $11M for arterial-plaque device (PE Hub)
Escoublac… Continue Reading